The Problem

Cancer rates continue to rise worldwide, with millions of people diagnosed each year. Early detection is crucial for effective treatment and improved patient outcomes. Unfortunately, many people do not have access to screening tests, and some screening methods can be invasive and uncomfortable. Our laboratory is working to change this by developing non-invasive and more accessible cancer screening tools.

28M

New Cases¹

16.2M

Deaths¹

41^%

of Men²

¹ Annual Global Cancer Burden by 2040

² American Cancer Society
Lifetime probability of being diagnosed with cancer in US

39^%

of Women²

We develop innovative solutions for modern healthcare challenges.

Our tear-based cancer screening tests bridge the gap between the current healthcare challenges and risk-tailored intervention.

Current Challenges

The current healthcare system has many outdated guidelines, multiple market and regulatory barriers, and unknown expenses. There is minimal input from the patient and any suggested outcomes are largely varied and generic, mostly based on age and average risk.

Our Vision

A better approach is precision medicine, value-based care based on specific risk factors that are affordable and easily accessible for all and based on education and informed decisions.

The Solution

How do we get there?

Accessible cancer screening tools for early detection to empower health outcomes for all.

We are the leader in tear-based proteomics, developing innovative solutions for the earlier detection of cancer. Tears are easily collected at home or in clinics, and due to their high concentration and sterility, lend themselves to the development of less expensive tests.

Why Tears

01

Preventive Care

Modern Testing

Our tear testing applications fully support the modern approaches to healthcare to focus on wellness, consumer engagement, and early detection of serious diseases. These approaches are being demanded from KOL’s in the industry and by major self-insured corporations.

Risk-based Screening

Our laboratory offers risk-based screening, which takes into account an individual's personal and family medical history, lifestyle factors, and other risk factors for cancer. By identifying those at higher risk, we can provide targeted screening options and early detection for those who need it most. Our risk-based screening approach is designed to provide more personalized and effective preventive care.

Product Pipeline

Our laboratory has a robust product pipeline, with ongoing research and development focused on improving cancer screening and preventive care. Our product pipeline includes new and innovative screening tests, as well as novel treatment options that are designed to improve patient outcomes. We are committed to advancing the field of cancer research and developing products that can make a real difference in the lives of patients.

02

Empowering Individual Health Ownership

The Quanitifed Self

We believe in empowering individuals to take control of their own health through the use of modern health sensors. From EKGs to glucose sensors, from fitness trackers to smartwatches like the iWatch, there are a variety of tools available to help consumers monitor their health and wellness on a daily basis.

By taking advantage of these tools, individuals can gain valuable insights into their health status and make more informed decisions about their lifestyle and healthcare.

03

Saving Lives through Patient Activation

Saving Lives

By empowering patients to make their own decisions about their health and wellness, we can help them find potential health issues early and take proactive steps to address them. We encourage patients to take responsibility for their own health and to be proactive in their health and wellness, rather than waiting for an event to happen before taking action.

When patients take control of their own health data, they can make more informed decisions about their healthcare and work with their healthcare providers to develop personalized care plans that are tailored to their individual needs.

Let’s impact.

We’re a revenue stage biotech company with big ideas, and the science to make them happen.

Be a part of the future of cancer screening.

Impact